… in multi-protein complexes in the cytoplasm and binds to ERE in nucleus, leading … effects
on the growth of ER positive breast cancer cells and exhibits anti-estrogen effect by reducing …

… (ERs; α and β), and by the G protein-coupled estrogen receptor 1 (GPER or … nucleus and
cytoplasm, with less than 2% present on the plasma membrane, and mediate genomic cellular …

… the receptor for its counterpart ligand—estrogen. Before being bound by estrogen, ER either
locates in the cytoplasm or nucleus … ER was predominantly detected in the cytoplasm of the …

… of SMYD3 into nucleus to activate HR genes transcription, we used nuclear/cytosol fractionation
assay to evaluate the changes of SMYD3 in nucleus and cytoplasm after IR treatment (…

… Cellular-abelsongene (c-Abl), a non-receptor tyrosine kinase distributed in both the
cytoplasm and the nucleus, is involved in cell proliferation, the cell cycle and cell migration by …

… The ER proteins are generally believed to shuttle between the cytoplasm and nucleus. In vitro
… activated co-activator for the steroid hormone receptors ER, AR, PR and growth hormone …

… To further demonstrate the compartments for the interactions of vimentin and pPPARγ, we
fractionated cellluar extracts into four different fractions, ie cytosol, membranes, nucleus, and …

… of IKKβ localizes in cytosol. IKKα and G9a could localize in nucleus and cytosol. Therefore,
… IKKβ interacts G9a in cytosol and IKKα interacts G9a in cytosol or nucleus. We would perform …

… β1 expression was the highest in EC. PR protein was localized in the nucleus and cytoplasm…
Dermatopontin inhibits papillary thyroid cancer cell proliferation through MYC repression[J]. …

… as an internal control, we found P4 cells expressing higher amounts of PRA/B then P0 cells.
… was detected in P0 then P4 cells. PRA were localized in the nucleus as well as cytoplasm. …